FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

23675011000001103: Vesomni 6mg/0.4mg modified-release tablets (Astellas Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 05-Feb 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
77337301000001118 Vesomni 6mg/0.4mg modified-release tablets (Astellas Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
77337401000001114 Vesomni 6mg/0.4mg modified-release tablets (Astellas Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Vesomni 6mg/0.4mg modified-release tablets (Astellas Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Vesomni 6mg/0.4mg modified-release tablets (Astellas Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Vesomni 6mg/0.4mg modified-release tablets (Astellas Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Vesomni 6mg/0.4mg modified-release tablets (Astellas Pharma Ltd) Is a Solifenacin 6mg / Tamsulosin 400microgram modified-release tablets true Inferred relationship Existential restriction modifier
Vesomni 6mg/0.4mg modified-release tablets (Astellas Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Vesomni 6mg/0.4mg modified-release tablets (Astellas Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Vesomni 6mg/0.4mg modified-release tablets (Astellas Pharma Ltd) Has specific active ingredient Tamsulosin hydrochloride true Inferred relationship Existential restriction modifier
Vesomni 6mg/0.4mg modified-release tablets (Astellas Pharma Ltd) Has specific active ingredient Solifenacin succinate true Inferred relationship Existential restriction modifier
Vesomni 6mg/0.4mg modified-release tablets (Astellas Pharma Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Vesomni 6mg/0.4mg modified-release tablets (Astellas Pharma Ltd) Has excipient Butylated hydroxytoluene false Inferred relationship Existential restriction modifier
Vesomni 6mg/0.4mg modified-release tablets (Astellas Pharma Ltd) Is a Vesomni true Inferred relationship Existential restriction modifier
Vesomni 6mg/0.4mg modified-release tablets (Astellas Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Vesomni 6mg/0.4mg modified-release tablets (Astellas Pharma Ltd) Has active ingredient Solifenacin true Inferred relationship Existential restriction modifier
Vesomni 6mg/0.4mg modified-release tablets (Astellas Pharma Ltd) Has active ingredient Tamsulosin true Inferred relationship Existential restriction modifier
Vesomni 6mg/0.4mg modified-release tablets (Astellas Pharma Ltd) Has manufactured dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Vesomni 6mg/0.4mg modified-release tablets (Astellas Pharma Ltd) 30 tablet 3 x 10 tablets Has AMP True Vesomni 6mg/0.4mg modified-release tablets (Astellas Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start